FT522

· Fate Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FT522, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) [Phase 1]